2bPrecise
2bPrecise CEO Assaf Halevy discusses how genomic information can be injected into the workflow to manage the treatment of the patient.
Joel Diamond, MD, CMO of 2bPrecise, discusses pharmacogenomics as a good entry point for providers in precision medicine, identifying the right medicine for better outcomes and patient satisfaction.